###### Strengths and limitations of this study

-   This is the first study into the relationship between vaginal herb use and a sexually transmitted infection (STI) in Suriname.

-   Moreover, determinants such as education and ethnic group are related to vaginal herb use.

-   Patients were recruited at two different settings, an STI outpatient clinic versus a family planning clinic, allowing a broader analysis of various populations.

-   We did not assess if vaginal herbs were used intravaginally and/or externally.

-   We did not study the effect of vaginal herb use on the vaginal microbiota.

Introduction {#s1}
============

Depending on cultural habits, women worldwide engage in a variety of vaginal hygiene practices, such as the use of intravaginal douches, herbal vaginal steam baths or the direct insertion of herbs into the vagina.[@R1] Studies in the USA showed that women who had less income, less education, were unmarried, lived in the southern States and were of African--American descent were more likely to engage in such practices when compared with white women.[@R2]

Vaginal practices are intended for feeling clean and fresh, getting rid of vaginal malodour, or removing residual menstrual blood,[@R5] and for improving the appearance of the vagina and for enhancing sensation during intercourse, and securing the relationship with, and economic support by the male partner.[@R2] However, these practices may increase the risk of acquiring infections, such as HIV,[@R4] human papiloma virus,[@R7] but also bacterial sexually transmitted infections (STI) and trichomoniasis.[@R8] Particularly, intravaginal practices, such as use of water and soap, the insertion of a cloth or a piece of paper into the vagina, to dry and tighten the vagina was associated with acquiring HIV.[@R4] An underlying mechanism for this may be that intravaginal practices deplete the relative amount of vaginal *Lactobacillus sp.* [@R4] Lactobacilli produce antimicrobials and acidify the vagina by lactic-acid production and are thus considered to be a hallmark for vaginal health; their depletion is known to mediate HIV and STI acquisition.[@R4]

Risk for STI may be further increased by a breakdown of the vaginal epithelial barrier and sometimes even the occurrence of lacerations.[@R3] In addition, a lack of vaginal fluids increases the risk of condom rupture. Although several studies have reported an association between vaginal practices and STI,[@R1] other studies did not.[@R15] Unfortunately, earlier studies did not consider the type of vaginal practice nor the frequency of their use.

Suriname is located on the northeast coast of South America, bordering the Atlantic Ocean to the north and surrounded by French Guiana to the east, Brazil to the south and Guyana to the west. The population of approximately 570 000 is characterised by the ethnical and cultural diversity. The largest ethnic groups are the Creoles and Maroons (both originating from enslaved Africans imported in the 17th to 19th century), and the Hindustani and Javanese (descendants from indentured labourers from the former British Indies and Dutch Indies respectively, who arrived around the turn of the 20th century). There are, in addition, Indigenous Amerindians, people of mixed descent, and descendants from Chinese labourers, European colonists and immigrants from various Latin American and Caribbean countries such as Brazil, Guyana, French Guiana, Haiti and Cuba.[@R17]

Among these ethnic groups, Afro-Surinamese women (Creoles and Maroons) in particular engage in a variety of vaginal practices including vaginal steam baths containing certain herbs for drying and tightening the vagina, cleansing after menstruation or after birth to prevent puerperal fever, 'placing the uterus back into position', or preventing a flabby abdominal wall.[@R3] Typically, for a herbal genital steam bath, a woman sits with spread legs on a bucket or bidet containing warm water with certain herbs to steam her inner genital parts. Depending on the herbs, the cooled down bath is used to wash the genital parts after steaming.[@R18] For direct internal application, Dettol (the brand name of the antiseptic chloroxylenol), yoghurt, lemon juice, vinegar as well as commercial products such as effervescent tablets, gels or emulsions are used. Commercial products in the form of wipes, emulsions, crèmes and mousses can also be used externally.[@R3]

In this study, we examined the type and frequency of vaginal practices in women visiting an STI outpatient clinic and a family planning (FP) clinic; in particular, the use of herbs and the reasons for their use were identified. Moreover, we assessed factors associated with vaginal herb use, and examined whether vaginal herb use is a determinant of cervicovaginal *Chlamydia trachomatis* infection.

Methods {#s2}
=======

The data used for the current study were gathered in the course of a larger study concerning chlamydia, the Urogenital Chlamydia Rapid Test Evaluation in Paramaribo and Amsterdam (CUSTEPA) study.[@R17]

Study population {#s2a}
----------------

Recruitment took place in Suriname's capital city Paramaribo in the period 2009--2010 at two locations: the Dermatological Service, an integrated outpatient STI clinic that offers free-of-charge examination and treatment of STIs and infectious skin diseases such as leprosy and leishmaniasis; and the Lobi Foundation, an FP clinic. The study was cross sectional, and each participant was given a unique code. Subsequently, a nurse interviewed the participant about demographic characteristics, including self-reported ethnic background, sexual behaviour, symptoms, STI history and vaginal hygiene. Criteria for exclusion were age below 18 years and previous participation within the CUSTEPA study.

Patient and public involvement {#s2b}
------------------------------

Representatives of the Maroon population were consulted on the outcome of the study.

Vaginal hygiene practices {#s2c}
-------------------------

Using a structured questionnaire, nurses asked women in detail about the use of products for vaginal practices such as douches, herbs or other home-made products, and if so, at which frequency. The questionnaires included several options such as the use of herbal genital steam baths, vinegar, water, yoghurt, and two often used commercial products: Lactacyd (Omega Pharma Nederland BV, Rotterdam, The Netherlands) that consists of lactic acid-containing wipes, crèmes, emulsion and mousses, and Dettol (Reckitt Benckiser Group, Slough, UK). Participants could specify the products they used. Precoded answer options for the frequency of vaginal practices were: daily, weekly, monthly or less than once a month. Women who used vaginal herbs were asked about their most recent application, and the reasons for use (hygiene, sexual pleasure, health or other). Items mentioned under reason 'other' that fitted one of the three former reasons were regrouped accordingly.

Specimen collection and testing procedures {#s2d}
------------------------------------------

Vaginal swabs were collected by trained nurses, stored and shipped to the Public Health Laboratory in Amsterdam, as described earlier.[@R19] Here, the samples were tested for *C. trachomatis* rRNA (APTIMA CT, Hologic Gen-Probe, San Diego, USA) according to the manufacturer's instructions. Test results were sent to the clinics in Suriname, and participants (and partners if indicated) were managed as described earlier.[@R19]

Statistical analysis {#s2e}
--------------------

To examine whether epidemiological characteristics and behaviour, including the use and frequency of vaginal practices, differed between women from the five major ethnic groups, characteristics and behaviours of these groups were compared using the χ^2^ test; age was compared using the Kruskal-Wallis test. Univariable logistic regression analysis was used to assess determinants for the use of vaginal herbs. In univariable analysis, the following variables were assessed: age, education, ethnic group, ethnicity of sexual partner, recruitment site, condom use, number of sexual partners in the preceding 1 and 12 month(s), having had sex in exchange for money or goods, and vaginal symptoms. Variables with p\<0.05 in univariable analysis were entered into multivariable logistic regression models; variables were removed stepwise until only significant variables were retained, but based on earlier studies age was forced into the model.[@R1] A second logistic regression analysis was conducted to assess whether vaginal herb use was independently associated with *C. trachomatis* infection. Variables univariately associated with *C. trachomatis* infection were entered into a multivariable model, and stepwise removed until only significant variables were retained; vaginal herb use was forced into the model. P values \<0.05 were considered statistically significant. SPSS statistics V.21 (IBM) was used for the analysis.

Results {#s3}
=======

Study population {#s3a}
----------------

We initially included 1093 women who self-identified with one of the following ethnic backgrounds: 17 (1.6%) Caucasian, 12 (1.1%) Chinese, 278 (25.4%) Creole, 256 (23.4%) Hindustani, 19 (1.7%) Indigenous, 163 (14.9%) Javanese, 138 (12.6%) Maroon, 205 (18.8%) mixed descent and 5 unknown (0.5%). Due to the small numbers, we excluded Caucasian, Chinese, Indigenous women and women with unknown background from further analysis. As a result, the study population included 1040 women of either Creole, Hindustani, Javanese, Maroon or mixed descent ([table 1](#T1){ref-type="table"}).

###### 

Epidemiological characteristics of Creole, Hindustani, Javanese, Maroon and mixed descent women (n=1040) recruited at the family planning clinic and sexually transmitted infections (STI) clinic, Paramaribo, Suriname, 2009--2010

                                                          Creole        Hindustani    Javanese      Maroon        Mixed descent   P value
  ------------------------------------------------------- ------------- ------------- ------------- ------------- --------------- --------------
  Demographic characteristics                                                                                                     
   Recruitment site                                                                                                               \<0.001
    Family planning clinic                                199 (71.6)    226 (88.3)    146 (89.6)    85 (61.6)     138 (67.3)      
    STI clinic                                            79 (28.4)     30 (11.7)     17 (10.4)     53 (38.4)     67 (32.7)       
   Median age in years (IQR)                              29 (24--35)   31 (26--39)   30 (25--36)   28 (23--34)   27 (23--33)     \<0.001
   Age in years                                                                                                                   
    \<25                                                  81 (29.1)     44 (17.2)     39 (23.9)     48 (34.8)     69 (33.7)       0.001
    25--29                                                64 (23.0)     63 (24.6)     41 (25.2)     29 (21.0)     53 (25.9)       
    30--34                                                60 (21.6)     50 (19.5)     33 (20.2)     30 (21.7)     40 (19.5)       
    ≥35                                                   73 (26.3)     99 (38.7)     50 (30.7)     31 (22.5)     43 (21.0)       
    Education                                                                                                                     \<0.001
    Low                                                   83 (29.9)     103 (40.2)    51 (31.3)     78 (56.5)     40 (19.5)       
    Medium                                                147 (52.9)    130 (50.8)    89 (54.6)     41 (29.7)     109 (53.2)      
    High                                                  43 (15.5)     21 (8.2)      21 (12.9)     9 (6.5)       52 (25.4)       
    Unknown                                               5 (1.8)       2 (0.8)       2 (1.2)       10 (7.2)      4 (2.0)         
  Symptoms                                                                                                                        
   Any symptoms                                           204 (73.4)    181 (70.7)    120 (73.6)    117 (84.8)    140 (68.3)      0.012
    Dysuria†                                              60 (21.8)     80 (31.2)     39 (23.9)     46 (33.6)     42 (20.6)       0.008
   Dyspareunia‡, §                                        66 (24.3)     73 (29.0)     41 (25.2)     41 (31.1)     51 (24.9)       0.506
    Change in fluor/vaginal discharge¶                    149 (54.0)    126 (49.2)    92 (56.4)     79 (57.7)     110 (53.7)      0.488
   Irregular menstruation\*\*                             81 (29.3)     71 (28.1)     32 (19.9)     51 (38.1)     52 (25.7)       0.012
    Abdominal pain††                                      106 (39.8)    106 (41.9)    67 (42.1)     74 (54.4)     78 (38.6)       0.041
  Vaginal hygiene                                                                                                                 
   Performs vaginal hygiene                               109 (39.2)    51 (19.9)     29 (17.8)     112 (81.2)    78 (38.0)       \<0.001
   Vaginal products used‡‡                                                                                                        
    Water                                                 35 (12.6)     28 (10.9)     17 (10.4)     29 (21.0)     31 (15.1)       0.039
    Herbs                                                 70 (25.2)     9 (3.5)       8 (4.9)       95 (68.8)     29 (14.1)       \<0.001
    Lactacyd                                              9 (3.2)       5 (2.0)       1 (0.6)       2 (1.4)       14 (6.8)        0.003
    Vinegar                                               9 (3.2)       2 (0.8)       4 (2.5)       2 (1.4)       9 (4.4)         0.118
    Dettol                                                4 (1.4)       4 (1.6)       0 (0.0)       0 (0.0)       0 (0.0)         0.105
    Other§§                                               10 (3.6)      7 (2.7)       2 (1.2)       1 (0.7)       4 (2.0)         0.314
   Frequency of vaginal hygiene¶¶, \*\*\*                                                                                         0.027
    Daily                                                 36 (43.9)     11 (32.4)     7 (41.2)      53 (63.1)     25 (39.7)       
    Once a week                                           18 (22.0)     12 (35.3)     3 (17.6)      19 (22.6)     11 (17.5)       
    Once a month                                          19 (23.2)     7 (20.6)      5 (29.4)      7 (8.3)       20 (31.7)       
    Less than once a month                                9 (11.0)      4 (11.8)      2 (11.8)      5 (6.0)       7 (11.1)        
   Reason for vaginal use of herbs‡‡,†††, ‡‡‡                                                                                     
    Hygiene                                               50 (71.4)     4 (44.4)      5 (62.5)      49 (51.6)     16 (55.2)       0.107
    Sexual                                                24 (34.3)     0 (0.0)       1 (12.5)      46 (48.4)     11 (37.9)       0.015, 0.485
    Health                                                11 (15.7)     0 (0.0)       1 (12.5)      16 (16.8)     2 (6.9)         --\*
    Other                                                 3 (4.3)       0 (0.0)       0 (0.0)       6 (6.3)       0 (0.0)         
   Last vaginal use of herbs§§§, ‡‡‡                                                                                              --\*
    Today                                                 7 (12.7)      0 (0.0)       0 (0.0)       19 (26.4)     1 (5.9)         
    Yesterday                                             5 (9.1)       0 (0.0)       0 (0.0)       23 (31.9)     1 (5.9)         
    Last week                                             20 (36.4)     0 (0.0)       2 (33.3)      15 (20.8)     4 (23.5)        
    More than a week ago                                  23 (41.8)     4 (100.0)     4 (66.7)      15 (20.8)     11 (64.7)       
  Sexual behaviour                                                                                                                
   Number of partners in the preceding month¶¶¶                                                                                   \<0.001
    0                                                     17 (6.2)      8 (3.1)       2 (1.2)       10 (7.5)      11 (5.7)        
    1                                                     237 (87.1)    236 (92.5)    148 (91.4)    117 (87.3)    158 (82.3)      
    2                                                     16 (5.9)      6 (2.4)       11 (6.8)      7 (5.2)       10 (5.2)        
    \>2                                                   2 (0.7)       5 (2.0)       1 (0.6)       0 (0.0)       13 (6.8)        
    Condom use during sex\*\*\*\*                                                                                                 \<0.001
    Always                                                49 (18.0)     17 (6.7)      10 (6.2)      23 (16.8)     37 (18.0)       
    Never or inconsistent                                 223 (82.0)    236 (93.3)    152 (93.8)    114 (83.2)    168 (82.0)      
   Number of partners in the preceding 12  months                                                                                 \<0.001
    0                                                     8 (2.9)       12 (4.7)      5 (3.1)       11 (8.0)      11 (5.4)        
    1                                                     208 (74.8)    209 (81.6)    123 (75.5)    82 (59.4)     127 (62.0)      
    2                                                     35 (12.6)     27 (10.5)     20 (12.3)     33 (23.9)     35 (17.1)       
    \>2                                                   27 (9.7)      8 (3.1)       15 (9.2)      12 (8.7)      32 (15.6)       
   Ethnic sexual mixing                                                                                                           
    Reported≥1 sexual partner from another ethnic group   89 (32.0)     45 (17.6)     80 (49.1)     43 (31.2)     123 (60.0)      \<0.001
   Sex in exchange for money or goods§                    7 (2.6)       6 (2.4)       0 (0.0)       5 (3.7)       19 (9.4)        \<0.001
   *Chlamydia trachomatis* infection††††                  37 (13.3)     16 (6.2)      25 (15.3)     15 (10.9)     29 (14.1)       0.022

*\**P values could not be obtained due to low numbers.

†Five missings.

‡Pain during sexual intercourse.

§Sixteen missings.

¶Three missings.

\*\*Fourteen missings.

††Twenty-four missings.

‡‡Multiple options could be chosen.

§§Other vaginal practices are products like lactacyd but from other brands; soap, antifungal and eggs.

¶¶Ninety-nine missings.

\*\*\*The denominator for the percentages is the group of women who indicated they performed vaginal hygiene.

†††Fifty-six missings, % of those who filled in the question,.

‡‡‡The denominator for the percentages is the group of women who indicated they performed vaginal hygiene.

§§§Fifty-seven missings.

¶¶¶Twenty-five missings.

\*\*\*\*Eleven missings.

††††As diagnosed by nucleic acid amplification test.

The majority of participants were recruited at the FP clinic (between 61.6% and 89.6% per ethnic background). The median age ranged from 27 years (IQR, 23--33 years) for mixed descent women to 31 years (IQR, 26--39 years) for Hindustani women (p\<0.001). Most women from Maroon descent (56.5%) had lower education whereas most of those from the other ethnic backgrounds had at least medium education (p\<0.001).

Vaginal symptoms were reported frequently, ranging from 68.3% (mixed descent women) to 84.8% (Maroon women; p=0.01). In all ethnic groups, more than 80% of women reported one sexual partner during the preceding month, and more than 60% reported one sexual partner during the preceding 12 months. Discordant mixing (intercourse with a partner of a different ethnic group) was most frequently seen among mixed descent and Javanese women (60.0% and 49.1%, respectively), followed by Creole, Maroon and Hindustani women. The prevalence of *C. trachomatis* infections was highest in Javanese women (15.3%) followed by mixed descent women (14.1%) and Creole women (13.3%) (p=0.02).

Vaginal hygiene {#s3b}
---------------

[Table 1](#T1){ref-type="table"} shows the ways in which vaginal hygiene was performed within the study population. Vaginal hygiene was most common in Maroon women (81.2%) followed by Creole (39.2%) and mixed descent women (38.0%). Between 10.4% and 21.0% of women used tap water for vaginal cleansing, with the largest proportion in Maroon (21.0%) and mixed descent women (15.1%). Lactacyd, vinegar and other substances such as Dettol were used less often.

In those women that performed vaginal hygiene, daily use was reported by Maroons (63.1%), Creoles (43.9%), Javanese (41.2%), mixed descent (39.7%) and Hindustani (32.4%).

Vaginal herb use {#s3c}
----------------

Vaginal herb use was reported most frequent by Maroon women (68.8%), followed by Creole women (25.2%), women of mixed descent (14.1%), Javanese (4.9%) and Hindustani (3.5%) ([table 1](#T1){ref-type="table"}). Hygiene was the most often mentioned reason for vaginal herb use (across all groups ranging from 68.1% to 100%), followed by sexual pleasure (ranging from 0% to 63.9%). Due to low numbers of women reporting vaginal herb use among women of Hindustani, Javanese and mixed descent, only Maroon and Creole women were included in the further analyses of vaginal herb use.

In univariable analysis, vaginal herb use was significantly associated with recruitment location, education, ethnic background, vaginal symptoms and abdominal pain ([table 2](#T2){ref-type="table"}). Although not significant, younger women reported vaginal herb use more often than women aged 35 years and above. In multivariable analysis, vaginal herb use was significantly associated with recruitment at the STI clinic (OR 2.04; 95% CI 1.24 to 3.36 vs the FP clinic), lower education levels (OR 3.80; 95% CI 1.68 to 8.57 lower vs higher education; and OR 2.02; 95% CI 0.90 to 4.51 medium vs higher education) and Maroon ethnicity (OR, 5.33; 95% CI 3.26 to 8.71 vs Creole). Although not significant in multivariable analysis, younger age was associated with vaginal herb use.

###### 

Univariable and multivariable logistic regression analyses of determinants associated with vaginal herb use among Creole and Maroon women, Paramaribo, Suriname, 2009--2010

                                                      Use of vaginal herbs   Univariable OR (95% CI)   P value   Multivariable-adjusted OR (95% CI)\*   P value
  --------------------------------------------------- ---------------------- ------------------------- --------- -------------------------------------- ---------
  Demographic characteristics                                                                                                                           
   Ethnic groups                                                                                                                                        
    Creole                                            70/278 (25.2)          1                         \<0.001   1                                      \<0.001
    Maroon                                            95/138 (68.8)          6.57 (4.18 to 10.30)                5.33 (3.26 to 8.71)                    
   Recruitment site                                                                                                                                     
    Family planning clinic                            96/284 (33.8)          1                         \<0.001   1                                      0.005
    STI clinic                                        69/132 (52.3)          2.15 (1.41 to 3.27)                 2.04 (1.24 to 3.36)                    
   Age in years                                                                                        0.068                                            0.067
    \<25                                              59/129 (45.7)          1.99 (1.15 to 3.42)                 2.23 (1.17 to 4.27)                    
    25--29                                            35/93 (37.6)           1.42 (0.79 to 2.57)                 1.78 (0.88 to 3.57)                    
    30--34                                            40/90 (44.4)           1.88 (1.04 to 3.40)                 2.23 (1.13 to 4.42)                    
    ≥35                                               31/104 (29.8)          1                                   1                                      
   Education†                                                                                          \<0.001                                          0.002
    Low                                               88/161 (54.7)          5.06 (2.38 to 10.79)                3.80 (1.68 to 8.57)                    
    Medium                                            59/188 (31.4)          1.92 (0.90 to 4.09)                 2.02 (0.90 to 4.51)                    
    High                                              10/52 (19.2)           1                                   1                                      
  Sexual behaviour                                                                                                                                      
   Number partners preceding month‡                                                                    0.106                                            
    0                                                 10/27 (37.0)           1                                                                          
    1                                                 135/354 (38.1)         1.05 (0.47 to 2.36)                                                        
    ≥2                                                15/25 (60.0)           2.55 (0.83 to 7.80)                                                        
   Number partners preceding 12 months                                                                 0.216                                            
    0                                                 9/19 (47.4)            1                                                                          
    1                                                 107/290 (36.9)         0.65 (0.26 to 1.65)                                                        
    ≥2                                                49/107 (45.8)          0.94 (0.35 to 2.50)                                                        
   Ethnic sexual mixing                                                                                                                                 
    No                                                115/284 (40.5)         1                         0.612                                            
    Yes                                               50/132 (37.9)          0.90 (0.59 to 1.37)                                                        
   Sex in exchange for money or goods§                                                                                                                  
    No                                                155/396 (39.1)         1                         0.191                                            
    Yes                                               7/12 (58.3)            2.17 (0.68 to 6.98)                                                        
  Symptoms                                                                                                                                              
   Any symptoms                                                                                                                                         
    No                                                24/95 (25.3)           1                         0.001                                            
    Yes                                               141/321 (43.9)         2.32 (1.39 to 3.87)                                                        
   Dysuria¶                                                                                                                                             
    No                                                114/306 (37.3)         1                         0.104                                            
    Yes                                               49/106 (46.2)          1.45 (0.93 to 2.26)                                                        
   Dyspareunia (pain during sexual intercourse)\*\*                                                                                                     
    No                                                113/297 (38.0)         1                         0.287                                            
    Yes                                               47/107 (43.9)          1.28 (0.82 to 2.00)                                                        
   Change in fluor/vaginal discharge††                                                                                                                  
    No                                                71/185 (38.4)          1                         0.619                                            
    Yes                                               93/228 (40.8)          1.11 (0.74 to 1.65)                                                        
    Irregular menstruation‡‡                                                                                                                            
    No                                                102/278 (36.7)         1                         0.122                                            
    Yes                                               59/132 (44.7)          1.40 (0.92 to 2.13)                                                        
   Abdominal pain§§                                                                                                                                     
    No                                                78/222 (35.1)          1                         0.026                                            
    Yes                                               83/180 (46.1)          1.58 (1.06 to 2.36)                                                        

\*ORs in the multivariable model are adjusted for all factors for which adjusted ORs are shown. In the final model, 401 participants were included.

†Fifteen missings.

‡Ten missings.

§Eight missings.

¶Four missings.

\*\*Twelve missings.

††Three missings.

‡‡Six missings.

§§Fourteen missings.

STI, sexually transmitted infections.

As described in [table 3](#T3){ref-type="table"}, a wide variety of herbs were used. Maroon women predominantly used 'kill somebody' or 'kill your darling *Dimorphandra conjugata* (Splitg.) Sandw. (Fabaceae)',[@R13] the 'jambolan or dyamu *Syzygium cumini* (L.) Skeels (Myrtaceae)',[@R9] the 'towel or wasduku *Clidemia capitellata* (Bonpl.) D. Don (Melastomataceae)',[@R9] the 'guavaberry or andoya *Campomanesia aromatica* (Aubl.) Griseb. (Myrtaceae)',[@R6] and 'pikin bë/witi baka píyjá páu (small red/white backed pineapple) *Vismia* Vand. sp. (Hypericaceae)'.[@R7] Creole women mostly mentioned 'sea island cotton or redikatun *Gossypium barbadense* L. (Malvaceae)'[@R16] in addition to the leaves of the 'tropical-almond or amandra *Terminalia catappa* L. (Combretaceae)', the 'mess apple or broko pi ('broken penis') *Bellucia grossularioides* (L.) Triana (Melastomataceae)', the 'guava or guyaba *Psidium guajava* L. (Myrtaceae)', the 'jungle geranium or faya lobi ('fiery love') *Ixora coccinea* L. (Rubiaceae)', and the 'ant bush or kapasiwiwiri ('herb of the nine-banded armadillo') *Siparuna guianensis* Aubl. (Monimiaceae)'.

###### 

Vaginal products mentioned among female participants performing vaginal hygiene, Paramaribo, Suriname, 2009--2010

  Vaginal product (scientific names if applicable)   Maroon ethnicity (n=112)   Creole ethnicity (n=109)   Other ethnicities\* (n=158)
  -------------------------------------------------- -------------------------- -------------------------- -----------------------------
  Almond leaves (*Terminalia catappa*)               1                          3                          1
  Andoya (*Campomanesia aromatica*)                  6                          1                          1
  Blaka masusa                                       0                          1                          0
  Blaka uma                                          0                          5                          2
  Broko pie (*Bellucia grossularioides*)             1                          1                          0
  Dettol                                             0                          4                          4
  Djamu (*Syzygium cumini*)                          9                          4                          0
  Douche gel                                         0                          0                          1
  Dram (alcohol)                                     0                          1                          0
  Eggs                                               0                          1                          0
  Eva products                                       0                          1                          0
  Faya lobi (*Ixora coccinea)*                       2                          0                          0
  Feififinga wiwiri                                  1                          1                          0
  Guave (*Psidium guajava)*                          3                          2                          0
  Intimate wash products                             0                          3                          5
  Kill somebody (*Dimorphandra conjugata)*           13                         4                          1
  Lactacyd                                           2                          9                          20
  Manjablad (Mango leaves)                           4                          9                          3
  Odany jewa                                         0                          0                          3
  Paraklem                                           4                          1                          0
  Pedreku                                            1                          1                          2
  Pikin bë (*Vismia* Vand. sp)                       7                          5                          14
  Redikatun (*Gossypium barbadense*)                 4                          16                         6
  Suku trobi                                         7                          3                          0
  Twigs                                              0                          0                          1
  Uma anesi                                          4                          1                          2
  Unknown leaves                                     13                         6                          6
  Vagisil                                            0                          1                          0
  Vinegar                                            2                          9                          15
  Wasduku (*Clidemia capitellata*)                   9                          1                          3
  Water                                              29                         35                         76
  Yarakopie                                          2                          3                          1
  Yoghurt                                            0                          0                          1

\*Hindustani, Javanese and mixed race ethnicity.

Vaginal herb use and *C. trachomatis* infection {#s3d}
-----------------------------------------------

Vaginal herb use was not associated with *C. trachomatis infection*, neither in univariable nor in multivariable analysis (adjusted OR \[aOR\], 1.20; 95% CI 0.65 to 2.22, p=0.564; [table 4](#T4){ref-type="table"}). In contrast, recruitment location, age and reporting sex in exchange for money or goods were associated with *C. trachomatis* infection in univariable analysis. In multivariable analysis, chlamydia infection was associated with recruitment at the STI clinic versus FP clinic (OR, 2.59; 95% CI 1.39 to 4.83; p=0.003) and also with younger age, both for \<25 years, and 25--29 years versus ≥35 years (resp aOR, 4.37; 95% CI 1.59 to 12.00, aOR 4.96; 95% CI 1.72 to 14.26 and aOR 1.20; 95% CI 0.33 to 4.35; p=0.002).

###### 

Univariable and multivariable logistic regression analyses of variables associated with cervicovaginal *Chlamydia trachomatis* infection among Creole and Maroon women, Paramaribo, Suriname, 2009--2010

                                                                     NAAT positive   Univariable OR (95% CI)   P value   Multivariable-adjusted OR (95% CI)\*   P value
  ------------------------------------------------------------------ --------------- ------------------------- --------- -------------------------------------- ---------
  Demographic characteristics                                                                                                                                   
   Ethnic group                                                                                                                                                 
    Creole                                                           37/278 (13.3)   1                         0.479                                            
    Maroon                                                           15/138 (10.9)   0.79 (0.42 to 1.50)                                                        
   Recruitment site                                                                                                                                             
    Family planning clinic                                           25/284 (8.8)    1                         0.001     1                                      0.003
    STI clinic                                                       27/132 (20.5)   2.66 (1.48 to 4.80)                 2.59 (1.39 to 4.83)                    
   Age in years                                                                                                0.001                                            0.002
    \<25                                                             25/129 (19.4)   4.76 (1.75 to 12.92)                4.37 (1.59 to 12.00)                   
    25--29                                                           17/93 (18.3)    4.43 (1.56 to 12.54)                4.96 (1.72 to 14.26)                   
    30--34                                                           5/90 (5.6)      1.17 (0.33 to 4.16)                 1.20 (0.33 to 4.35)                    
    ≥35                                                              5/104 (4.8)     1                                   1                                      
   Education                                                                                                   0.444                                            
    Low                                                              19/161 (11.8)   1.03 (0.39 to 2.73)                                                        
    Medium                                                           23/188 (12.2)   1.07 (0.41 to 2.78)                                                        
    High                                                             6/52 (11.5)     1                                                                          
    Unknown                                                          4/15 (26.7)     2.79 (0.67 to 11.60)                                                       
  Vaginal hygiene                                                                                                                                               
   Performed vaginal hygiene                                                                                                                                    
    No                                                               21/195 (10.8)   1                         0.317                                            
    Yes                                                              31/221 (14.0)   1.35 (0.75 to 2.44)                                                        
   Herb use                                                                                                                                                     
    No                                                               27/251 (10.8)   1                         0.187     1                                      0.564
    Yes                                                              25/165 (15.2)   1.48 (0.83 to 2.66)                 1.20 (0.65 to 2.22)                    
   Frequency of performing vaginal hygiene†                                                                                                                     
    Daily                                                            16/89 (18.0)    1.82 (0.90 to 3.68)       0.282                                            
    At least once a week                                             7/36 (19.4)     2.00 (0.78 to 513)                                                         
    At least once a month                                            2/25 (8.0)      0.72 (0.16 to 3.28)                                                        
    Less then once a month                                           3/14 (21.4)     2.26 (0.58 to 8.76)                                                        
    Never                                                            21/195 (10.8)   1                                                                          
  Sexual behaviour                                                                                                                                              
   Number of partners preceding month‡                                                                                                                          
    0--1                                                             43/381 (11.3)   1                         0.018                                            
    ≥2                                                               7/25 (28.0)     3.06 (1.21 to 7.74)                                                        
   Condom use§                                                                                                                                                  
    Always                                                           11/72 (15.3)    1.30 (0.63 to 2.68)       0.473                                            
    Never or inconsistent                                            41/337 (12.2)   1                                                                          
   Number of partners in the preceding 12 months                                                                                                                
    0--1                                                             37/309 12.0)    1                         0.582                                            
    ≥2                                                               15/107 (14.0)   1.20 (0.63 to 2.28)                                                        
   Ethnic sexual mixing                                                                                                                                         
    Reported only sexual partners from own ethnic group              32/284 (11.3)   1                         0.267                                            
    Reported at least one sexual partner from another ethnic group   20/132 (15.2)   1.41 (0.77 to 2.57)                                                        
   Sex in exchange for money or goods¶                                                                                                                          
    No                                                               47/396 (11.9)   1                         0.038                                            
    Yes                                                              4/12 (33.3)     3.71 (1.08 to 12.81)                                                       

\*ORs in the multivariable model are adjusted for all factors for which adjusted ORs are shown. In the final model, 416 participants were included.

†Fifty-seven missings.

‡Ten missings.

§Seven missings.

¶Eight missings.

NAAT, nucleic acid amplification test; STI, sexually transmitted infection.

Discussion {#s4}
==========

We assessed the use and frequency of various vaginal practices among female STI clinic and FP clinic visitors in Suriname, and found that: (1) vaginal practices are commonly used, and most frequently by Maroon, Creole and mixed decent women; (2) vaginal herb use is more common among women with lower education; (3) vaginal herb use is most frequently practised for hygienic reasons and (4) vaginal herb use is not associated with *C. trachomatis* infection.

Ethnic background was the most important determinant for vaginal herb use. The extensive vaginal use of herbs among Maroon women has previously been described in French Guiana, where a prevalence of 96.1% was found.[@R21]

Women who experienced vaginal symptoms were more likely to engage in vaginal herb use. Since this is a cross-sectional study, it is not clear if vaginal symptoms are a cause, or an effect of vaginal practices. A Cambodian study also found an association between vaginal douching and vaginal symptoms.[@R22] Similarly, female sex workers in China were more likely to engage in vaginal practices when having STI-related symptoms, and reportedly engaged more in vaginal douching when experiencing vaginal symptoms.[@R23] In contrast, a study with Jamaican women who attended a public STI clinic found that vaginal itching led to a lower frequency of vaginal douching.[@R24] Prospective (intervention) studies could shed light on any casual links between vaginal practices and vaginal symptoms. The high prevalence of vaginal herb use among Maroon women has been previously reported, and it is conceivable that Maroon women do not engage in vaginal herb use as consequence of vaginal symptoms but rather out of (cultural) habit.[@R21]

As previously described, hygiene was the most important reason for vaginal herb use, followed by sexual reasons.[@R3] Moreover, Maroon women mentioned as a reason to make oneself more attractive for one's partner.

We found no association between vaginal herb use and infection with *C. trachomatis*. This confirms earlier findings of the above-mentioned Chinese study where no association was found among sex workers between vaginal practices (mostly disinfectants after sex with clients) and STI (syphilis, *Neisseria gonorrhoea* and *C. trachomatis* combined).[@R23]

This study has some limitations. This study did not assess the mode of vaginal practices, for example, whether the products were applied intravaginally and/or externally. Previous studies have found associations between the internal use of vaginal practices and HIV.[@R4] Therefore, we cannot exclude that the lack of association between vaginal herb use and *C. trachomatis* infection may be explained by predominantly external use of herbs. Moreover, we did not study the effect of vaginal herb use on the vaginal microbiota. Lactobacilli generally constitute a healthy vaginal microbiota as they generate an acidic environment (pH 4.0--4.5) and produce antimicrobials, that restrict the growth of most pathogens.[@R25] A non-lactobacillus-dominated vaginal microbiota is thus considered dysbiotic. Intravaginal practices have been linked to developing vaginal dysbiosis,[@R4] but these studies studied douching behaviour in general and did not differentiate between different types of intravaginal products. The use of an over-the-counter lactic acid containing douche was recently studied prospectively among healthy Dutch women and this was not found to significantly impact the vaginal microbiota composition, although an increased odds for having non-lactobacillus-dominated vaginal microbiota among users was observed.[@R28] Additionally, douching significantly increased the odds for testing positive for *Candida albicans.* Three douching intervention studies failed to show a significant effect of douching cessation on the vaginal microbiota,[@R9] although one study did observe significantly reduced candidiasis prevalence.[@R30] The specific effect of herb use on the vaginal microbiota is currently unknown and may differ by study population and by specific herb used. Compared with Caucasian women, women of African descent are more likely to have vaginal microbiota not dominated by *Lactobacillus sp.* [@R11] More research is needed to evaluate the impact of vaginal herb use on the vaginal microbiome and its potential to cause dysbiosis. Since vaginal herb use involves female hygiene, sexuality and cultural identity, it is considered a sensitive subject in Surinamese society.[@R33] Therefore, the anthropological and psychological aspects of vaginal herb use should be studied in detail to shed more light on this widely used phenomenon.

In conclusion, in the multiethnic society of Suriname, many Maroon and Creole women use vaginal herbs. Apart from ethnic group, education and being recruited at an STI clinic (as opposed to an FP clinic) were the main determinants for vaginal herb use. Vaginal herb use was not associated with *C. trachomatis* infection. Whether vaginal herb use has beneficial or possible negative effects on female health needs to be assessed in future studies.

Supplementary Material
======================

###### Reviewer comments

###### Author\'s manuscript

The author would like to thank Leslie O A Sabajo, all nurses and laboratory technicians of the Dermatological Service and the Lobi Foundation for data collection, and Titia Heijman for helpful suggestions.

**Contributors:** JJVdH collected the data, analysed the data and wrote the manuscript; MFSvdL supervised the analysis and wrote the manuscript; EdV analysed the data and wrote the first manuscript draft; CvdV wrote the manuscript; AWG designed the study, collected data and wrote the manuscript; DM collected the data and wrote the manuscript; and HJCdV designed the study, and wrote the manuscript.

**Funding:** This work was supported by the Research and Development fund of the Public Health Service of Amsterdam \[project nos 2369 and 2371\] and AGIS healthcare insurance \[RVVZ no 1417000\].

**Competing interests:** None declared.

**Ethics approval:** The study was approved by the Ethics Committees of the Ministry of Health of the Republic of Suriname (VG010-2007) and the Academic Medical Center, University of Amsterdam, The Netherlands (MEC07/127).

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Data sharing statement:** Deidentified participant data are available upon request through the corresponding author HJCdV. ORCID identifier 0000-0001-9784-547X.

**Correction notice:** This article has been corrected since it first published online. The open access licence type has been amended.

**Patient consent for publication:** Not required.
